Cf. Allaart et al., SURVIVAL IN FAMILIES WITH HEREDITARY PROTEIN-C DEFICIENCY, 1820 TO 1993, BMJ. British medical journal, 311(7010), 1995, pp. 910-913
Objectives-To establish the survival of individuals heterozygous for h
ereditary protein C deficiency, who have an increased risk of venous t
hrombotic events, and to compare it with the survival of the general p
opulation. Design-Retrospective study in pedigrees of 23 families with
hereditary protein C deficiency for period 1820 and 1993. Setting-23
completed family trees of 24 probands from various parts of the Nether
lands with symptoms of protein C deficiency. Subjects-All 736 members
of the 23 families with a 50% or 100%, probability of being (or having
been) heterozygous for the genetic defect on the basis of DNA analysi
s or their place in the pedigrees, following mendelian rules. Main out
come measures-Observed mortality compared with the mortality of the ge
neral Dutch population; the standardised mortality ratio was calculate
d by dividing the observed mortality by the expected mortality. Result
s-No excess mortality was found in the 206 proved heterozygous individ
uals and ''obligatory transmitters'' (those who have definitely passed
on the deficiency) (standardised mortality ratio 0.95 (95% confidence
interval 0.5 to 1.2)) or in the 530 family members with a 50%, geneti
c probability of heterozygosity (1.10 (0.9 to 1.3)). Conclusion-Hetero
zygous individuals with hereditary protein C deficiency type I have no
rmal survival compared with the general population. Prophylactic antic
oagulant treatment may prevent thrombotic events in heterozygous indiv
iduals but may not be expected to improve their survival.